Author: Early Investing

Early Investing’s mission is to help its readers find the most promising investment opportunities outside the stock market. Our research is focused on two areas in particular: private startups and cryptocurrencies. We provide both educational material and recommendations on specific investments. With more than 140,000 readers and 40,000 subscribers, Early Investing is a leading destination for guidance in the alternative investment space.

Subscribe to Early's feed.

Startup Insider: How NowRx Works With Google Home

By Early Investing on November 7, 2019

In Part 2 of our interview with NowRx, we go behind the scenes to see how the company tracks orders, maps out delivery routes and more.
Premium

Recommendation: Reinvest in NowRx

By Early Investing on November 4, 2019

Today’s Startup Insider video features the founders of NowRx, a startup that’s disrupting the brick-and-mortar pharmacy industry. In Part 1 of this interview, they discuss what they do, what inspired them to start the company and more.
In this week’s Mailbag, the Early Investing team explains why altcoins are underperforming and how today’s startup deal flow is better than ever.
Premium
Cannabis is a brand-new industry filled with promising startups attacking all angles of the market. New products are hitting the shelves and attracting customers. And the U.S. cannabis market is already worth billions of dollars. But a brand-new market also comes with difficulties. Cannabis is still illegal at the…

Mailbag: Defining Reasonable Revenue Growth

By Early Investing on October 27, 2019

In this week’s Mailbag, the Early Investing team explains reasonable revenue growth numbers and underperforming IPOs.
Premium
Summary The Securities and Exchange Commission (SEC) has rejected yet another Bitwise bitcoin exchange-traded fund (ETF) proposal. This is exactly what we expected to happen. But this time, the SEC did something we didn’t expect: It actually gave constructive feedback in the form of a detailed 112-page response. Adam…
Premium
In Part 2 of our interview with David Nikzad, we learn more about his company Orthogonal Thinker and what it’s doing to improve the world.

Mailbag: Lessons Learned From Bad Investments

By Early Investing on October 20, 2019

In this week’s Mailbag, Andy Gordon shares what he learned from the worst investment he ever made and Adam Sharp explains why he’s not buying Beyond Meat.
Premium

Cannabis Report: Uncertainty Should Be Baked Into the Market

By Early Investing on October 17, 2019

The cannabis industry is taking it too personally when just one or two companies have a bad day. Fortunately, there are buying opportunities amid the bad news.
Premium
If you read any of Andy Gordon’s startup recommendations, you know about his “four M’s” criteria. He uses the four M’s (management, market, monetization and metrics) to evaluate potential startup investments. Today’s video takes a deep dive into each of these criteria. Andy covers a wide range of topics…

Mailbag: Don’t Dismiss Sectors or Cannabis Stocks

By Early Investing on October 13, 2019

In this week’s Mailbag, the Early Investing team tackles cannabis stocks and startup sectors.
Premium
In the crypto world this week, Coinbase offers interest on its stablecoin, a Crypto Rating Council forms to rate cryptocurrencies based on their likelihood of becoming securities and Block.one gets a slap on the wrist from the SEC.
Premium
Imagine a Berkshire Hathaway that invests only in companies developing products that are good for the body. Orthogonal Thinker founder David Nikzad is doing just that. And it’s a very personal mission.

Mailbag: Early Investors Don’t Need to Worry About WeWork

By Early Investing on October 6, 2019

In this week’s Mailbag, the Early Investing team addresses celebrity investors and the WeWork debacle’s impact on the startup investing world.
Premium
The House made history last week when it passed the first marijuana reform law ever. But there are a couple of reasons why this bill may not make it past the Senate.